CClinicalTrials.gg
CompletedNCT06912516Updated Apr 4, 2025

PULSE OXIMETRY Performance Test for a Software Medical Device 'Vitacam'

An interventional study of Controlled desaturation in Pulse Oximetry, sponsored by Vitacam. Completed at 1 site in Finland. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-04.

Sponsored by Vitacam · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Dec 2023, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This clinical investigation aims to collect data for algorithm development and testing of Vitacam as well as to later validate the system using a simultaneously collected, but segregated, hold-out validation dataset. Vitacam is a software medical device for measuring vital signs, manufactured by NE Device SW Oy. It analyses digital video recorded using a smart device with a camera to locate a subject's face and chest region. From both these regions of interest, the video is further analysed to obtain the heart rate, heartbeat intervals, respiratory rate and oxygen saturation. These measurements are used as inputs to clinical decision making. Vitacam uses remote photoplethysmography to obtain the heart rate and heartbeat intervals, and will build on this to obtain oxygen saturation using information from red-green-blue channels.

The main focus of this study is to validate the oxygen saturation, heart rate and heartbeat intervals measured by Vitacam against gold standard references, applying the ISO 80601:2019 standard.

02

Conditions studied

  • Pulse Oximetry

Keywords

  • Oxygen saturation
  • remote photoplethysmography
  • pulse oximetry
03

In context

Lead sponsor

This is the only study on the registry with Vitacam as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age: 18-40 years
  • ASA category 1
  • Positive Allen's test
  • Passing the physical examination
  • Ability to give informed consent
  • Volunteering for the study
  • Fluent Finnish or English

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years or over 40 years
  • Smoker
  • Pregnancy
  • Does not pass the physical examination
  • Negative Allen's test
  • Relevant medical illnesses
  • Cardiovascular disease
  • Pulmonary disease
  • Inability to give informed consent
  • Denial
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Other
    Desaturation subjects

    This is a single arm study where healthy volunteers were subjected to a controlled desaturation protocol to ascertain if the investigational device could correctly track changes in oxygen saturation.

    Procedure: Controlled desaturation

Interventions

  • ProcedureControlled desaturation

    A subject rests comfortably on a hospital bed, so that they do not have to move during the desaturation process. The subject wears the altitude simulator head bivy and breathes freely without any oxygen regulation. During the measurement, the time in low O2 saturation plateaus is limited to ten minutes in each desaturation plateau. They are monitored with ECG, clinical pulse oximeter, EtCO2 from non-invasive capnography with nasal cannulas and periodically non-invasive blood pressure. The monitoring is supervised by two medical doctors, present during the entire duration of the study.

06

What researchers measure

Primary outcomes

  1. Accuracy of oxygen saturation measurements - Root Mean Square Error

    Accuracy as measured by Root Mean Square Error should be less than or equal to 4% for SpO2 as per ISO 80601-2-61:2019. It is calculated from the difference of the SpO2 measured from the investigational device and that of the reference device.

    Time frame: A 30-45 minute period during which the participant is subjected to the de-saturation process

  2. Accuracy of oxygen saturation measurements - Mean absolute error

    Accuracy as measured by Mean Absolute Error should be less than or equal to 4% for SpO2 as per ISO 80601-2-61:2019. It is calculated from the difference of the SpO2 measured from the investigational device and that of the reference device.

    Time frame: A 30-45 minute period during which the participant is subjected to the de-saturation process

Secondary outcomes

  1. Accuracy of interbeat intervals of the investigational device against successive R waves of the QRS complex from an Electrocardiogram

    To validate the accuracy of Vitacam interbeat intervals, both the intervals and heart rate variability metrics derived from these intervals, will be compared to the RR intervals and heart rate variability metrics derived from a 5-lead ECG

    Time frame: A 30-45 minute period during which the participant is subjected to the de-saturation process

07

Study locations

1 site
  • Tampere University
    Tampere, FI-33014, Finland
08

References and documents

Individual participant data

Plan to share: No — IPD cannot be shared due to GDPR

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06912516
Lead sponsor
Vitacam
Collaborators
Tampere University, Tampere University Hospital
Responsible party
Sponsor
First posted
Apr 4, 2025
Start date
Dec 22, 2023
Primary completion
Sep 15, 2024
Completion
Nov 1, 2024
Last update
Apr 4, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion